Willow Live

Dr. Samuel Thomas Connolly

MD

About

A seasoned Emergency Medicine physician, Dr. Samuel T. Connolly, MD has been practicing for over 25 years. He earned his degree from the University of Massachusetts Medical School and completed his residency at UMass Chan Medical School. Dr. Connolly is affiliated with Milford Regional Medical Center in Massachusetts and licensed in more than ten states, offering care in a wide range of emergency settings.

With a career built on high-pressure decision-making, he remains grounded through an active lifestyle and family time—habits that help him maintain the focus his patients rely on.

Education

University of Massachusetts Medical Center

Feeling great
has never been so easy

Our doctors are excited to meet you, and ready to help you thrive.

Personalized medication

Each batch of medication is custom-formulated to match your individual health needs and treatment plan.

100% online

In-stock now, with same-day approval and free two-day shipping to your doorstep.

Comprehensive support

Includes doctor messaging, free follow-ups, video guides, and our peer community.

START MY FREE VISIT

TERMS & CONDITIONS PRIVACY TELEHEALTH INFORMED CONSENT BILL OF RIGHTS

Subscribe now for exclusive health and wellness insights!

By signing up to receive emails from Willow, you agree to our Privacy Policy. We treat your info responsibly. Unsubscribe anytime.

The recognized brand name medications Zepbound™ and Mounjaro® are manufactured by Eli Lilly and Company™. The brand name medications Wegovy® and Ozempic® are manufactured by Novo Nordisk A/S. Willow does NOT manufacture or distribute these medications and has no direct affiliation with Eli Lilly and Company™ or Novo Nordisk A/S.

The products offered by Willow are compounded medications prepared by licensed compounding pharmacies. These formulations are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to evaluate their safety, efficacy, or therapeutic equivalence to any FDA-approved medications. They are not intended to diagnose, treat, cure, or prevent any disease and are not substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. Any claims regarding effectiveness, safety, or weight loss benefits relate only to general mechanisms of the active ingredients (e.g., tirzepatide or semaglutide) and do not pertain to Willow's specific compounded formulations. These products are not approved for cosmetic weight loss and should only be used under the supervision of a licensed healthcare provider. By purchasing or using these products, you acknowledge and accept these terms.

The recognized brand name medications Zepbound™ and Mounjaro® are manufactured by Eli Lilly and Company™. The brand name medications Wegovy® and Ozempic® are manufactured by Novo Nordisk A/S. Willow does NOT manufacture or distribute these medications and has no direct affiliation with Eli Lilly and Company™ or Novo Nordisk A/S.

The products offered by Willow are compounded medications prepared by licensed compounding pharmacies. These formulations are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to evaluate their safety, efficacy, or therapeutic equivalence to any FDA-approved medications. They are not intended to diagnose, treat, cure, or prevent any disease and are not substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. Any claims regarding effectiveness, safety, or weight loss benefits relate only to general mechanisms of the active ingredients (e.g., tirzepatide or semaglutide) and do not pertain to Willow's specific compounded formulations. These products are not approved for cosmetic weight loss and should only be used under the supervision of a licensed healthcare provider. By purchasing or using these products, you acknowledge and accept these terms.